Latest News & Features
Americas
Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis. 14 November 2018
Americas
Gene-editing company CRISPR Therapeutics has expanded its partnership with US-based MaxCyte, which focuses on cell-based medicines, into the immuno-oncology arena. 13 November 2018
Big Pharma
Associations representing the pharmaceutical and biotechnology fields have said that the UK should maintain “close cooperation” with the EU post-Brexit, to ensure that access to safe and effective medicines continues in both markets. 12 November 2018
Africa
Jordan-based Hikma Pharmaceuticals and British pharmaceutical company Vectura Group have united to develop generic versions of GSK’s Ellipta respiratory products. 12 November 2018
Americas
A jury has said that Flexus Biosciences, a company owned by Bristol-Myers Squibb, does not need to pay damages despite being liable for trade secrets misappropriation. 12 November 2018
Americas
A new facet of Mexico’s linkage system between patents and pharmaceutical drugs raises several questions that necessitate a careful approach from patent assignees and agents, as Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reports. 12 November 2018
Americas
The strongest cannabidiol patent portfolios are owned by Roche, Boehringer Ingelheim, and AbbVie, according to a report released earlier this week. 9 November 2018
Biotechnology
The European Patent Office has revoked a Bayer-owned patent which covers a type of broccoli adapted to make their harvesting easier. 9 November 2018
Americas
Biotech company Momenta has obtained the rights to use AbbVie’s Humira IP, enabling the global commercialisation of Momenta’s proposed Humira biosimilar, M923. 8 November 2018
Big Pharma
The Swiss Federal Institute of Intellectual Property has issued a notice covering a change in the practice for granting supplementary protection certificates (SPCs), following a landmark decision by Switzerland’s highest court. 8 November 2018